This Article is not live.
ARTICLE
13 May 2025
The EU Biotech Act Has Been Delayed — Here's What That Means
Arnold & Porter
Contributor
Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies.
